Kitov Pharamceuticals Holdings Stock Company Profile

Description

Kitov Pharmaceuticals Holdings Ltd., through its subsidiary, Kitov Pharmaceuticals Ltd., operates as a clinical development stage biopharmaceutical company. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and hypertension. The company’s lead drug candidate is KIT-302, a fixed dosage combination product based on the generic drugs celecoxib and amlodipine besylate that has completed its Phase III clinical study. It is also developing KIT-301, which is based on the generic drugs naproxen and isradipine. Kitov Pharmaceuticals Holdings Ltd. was founded in 2010 and is based in Tel Aviv, Israel.